Gestamp Automocion SA (GEST)
Madrid Exchange · Spain · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 2.880 |
|---|---|
| 52-week range | 2.760 – 3.460 |
| Return, 1 month / 3 months | −6.2% / +1.9% |
| Return, 1 year / 3 years | −9.7% / −13.8% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 26.5% |
| Worst drawdown (1 year) | -18.2% |
| Average daily value traded | 0.73M EUR |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gestamp Automocion is a Spanish automotive supplier that designs and makes metal components for vehicles. Its products include structural body parts, chassis components and mechanisms that go into cars and light vehicles. The company works with vehicle manufacturers around the world, supplying parts for their assembly lines. It is based in Spain and operates as a tier-one supplier to the automotive industry, focusing on metal forming and assembly work for passenger cars and other vehicles.
On this site Gestamp Automocion SA appears as a stock on the Madrid Exchange (Spain), code GEST, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gestamp Automocion SA (GEST) trades on the Madrid Exchange in Spain. It last closed at EUR 2.880 on 22 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 126 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.7% and over the last three months it rose 1.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -4.9% | ||
| From 52-week high | -16.5% | ||
| Momentum | 50 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 1.9% | ||
| 6-month return | -8.8% | ||
| 12-month return, skipping the last month | -3.8% | ||
| Stability (higher is calmer) | 50 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.2% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 0.73M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 42 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | −6.2% |
| 3 months | +1.9% |
| 6 months | −8.8% |
| 1 year | −9.7% |
| 3 years | −13.8% |
| 5 years | −9.0% |
Signals
| 50-day / 200-day average | 2.963 / 3.029 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.075 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Jun 2026 | EUR 0.0334 |
| 12 Jan 2026 | EUR 0.0317 |
| 30 Jun 2025 | EUR 0.0414 |
| 10 Jan 2025 | EUR 0.0392 |
| 1 Jul 2024 | EUR 0.0626 |
| 8 Jan 2024 | EUR 0.0567 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.